参考文献/References:
［1］ Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective［J］. Oncologist, 2010, 15: 5- 13.
［2］ Tu J, Ji J, Wu F, et al. Effectiveness of combined 131I- chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinoma［J］. Cell Biochem Biophys, 2015, 71: 777- 784.
［3］ 杨甲梅． 重视复发性原发性肝癌的外科治疗［J］． 临床外科杂志， 2005， 13： 129- 130．
［4］ 孙 燕， 赵 平． 临床肿瘤学进展［M］． 北京： 中国协和医科大学出版社， 2005： 656- 668．
［5］ 葛乃建， 杨业发， 申淑群， 等． 经皮穿刺射频消融治疗门静脉癌栓15例［J］． 介入放射学杂志， 2014， 23： 883- 886．
［6］ Kobayshi M, Ikeda K, Kawamura Y, et al. Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma—direct ablative effects and a long- term outcome［J］. Liver Int,2007, 27: 353- 359.
［7］ Tu JF, Xu HH, Ying XH, et al. Comparative study of several microinvasive treatments for large hepatocellular carcinoma［J］. Eur Rev Med Pharmacol Sci, 2015, 19: 45- 53.
［8］ Peng ZW, Zhang YJ, Chen MS, et al. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma［J］. Surg Oncol, 2008, 17: 23- 31.
［9］ 杜锡林， 王义清， 马庆久， 等． 肝动脉栓塞对射频治疗肝癌的影响［J］． 介入放射学杂志， 2004， 13： 50- 52．
［10］ Suzuki H, Mori M, Kawaguchi C, et al. Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma［J］. Int J Oncol, 1999, 14: 1087- 1090.
［11］ Ranieri G, Gadaleta- Caldarola G, Goffredo V, et al. Sorafenib （BAY 43-9006） in hepatocellular carcinoma patients: from discovery to clinical development［J］. Curr Med Chem, 2012, 19: 938- 944.
［12］ Wiedmann MW, Mossner J. Molecular targeted therapy of hepatocellular carcinoma- results of the first ciinical studies［J］. Curr Cancer Drug Targets, 2011, 11: 714- 733.
［13］ Lacouture ME, Wu S, Robert C, et al. Evolving strategies for the management of hand- foot skin reaction associated with the multitar- geted kinase inhibitors sorafenib and sunitinib［J］. Oncologist, 2008, 13: 1001- 1011.
［14］ 张惠洁， 郭卫东． 索拉菲尼在肿瘤治疗中的研究进展［J］． 中华临床医师杂志： 电子版， 2013， 7： 137- 139．
［15］ Sasaki A, Iwashita Y, Shibata K, et al. Preoperative transcatheter arterial chemoembolization reduces long- term survival rate after hepatic resection for resectable hepatocellular carcinoma［J］. Eur J Surg Oncol, 2006, 32: 773- 779.
［16］ Jenab- Wolcott J, Giantonio BJ. Bevacizumab: current indications and future development for management of solid tumors［J］. Expert Opin Biol Ther, 2009, 9: 507- 517.
［17］ Dal Lago L, D’hondt V, Awada A. Selected combination therapy with sorafenib: A review of clinical data and perspectives in advanced solid tumors［J］. Oncologist, 2008, 13: 845- 858.
［18］ Kelley RK, Venook AP. Sorafenib in hepatocellular carcinoma: separating the hype from the hope［J］. J Clin Oncol, 2008, 26:5845- 5848.
［19］ 刘 冲． 索拉菲尼对肝癌HepG2细胞的抑制作用及其对CDK5表达水平的影响［D］． 太原： 山西医科大学， 2013．
［20］ Wilhelm SM, Carter C, Tang L, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis［J］. Cancer Res, 2004, 64: 7099- 7109.
［21］ Chang YS, Adnane J, Trail PA, et al. Sorafenib （BAY 43-9006） inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models［J］. Cancer Chemother Pharmacol, 2007, 59: 561- 574.
［22］ Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma［J］. N Engl J Med, 2008, 359: 2498- 2499.
［23］ Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia- Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double- blind, placebo- controlled trial［J］. Lancet Oncol, 2009, 10: 25- 34.
［24］ Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofre quency tissue ablation: does perfusion mediated tissue cooling limitcoagulation necrosis?［J］. J Vasc Interv Radiol, 1998, 9: 01- 111.
［25］ Ikeda K, Seki T, Umehara H, et al. Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy［J］. Int J Oncol, 2007, 31: 485- 491.
相似文献/References:
[1]张 琳,黄学全,王健,等.自主研发电化学治疗同轴电极与传统针式电极电解效应的对比研究[J].介入放射学杂志,2012,(02):148.
ZHANG Lin,HUANG Xue-quan,WANG Jian,et al.The electrolytic effect in electrochemotherapy: a comparative study between self-prepared coaxial electrode and conventional needle electrode[J].journal interventional radiology,2012,(12):148.
[2]赵 玮,王伟中,陈莹,等.耳部动静脉畸形供血动脉的血管造影研究[J].介入放射学杂志,2012,(02):103.
ZHAO Wei,WANG Wei-zhong,CHEN Ying,et al.Angiographic findings of the feeding arteries of auricular arteriovenous malformations[J].journal interventional radiology,2012,(12):103.
[3]邹俊民,龙世娟,张振明. 改良髂内动脉化疗联合放疗治疗Ⅲ~Ⅳa期 子宫颈癌32例[J].介入放射学杂志,2012,(02):123.
ZOU Jun-min,LONG Shi-Juan,ZHANG Zheng-ming..Improved internal iliac artery chemotherapy combined with radiotherapy for the treatment of stage Ⅲ-Ⅳa cervical cancers[J].journal interventional radiology,2012,(12):123.
[4]王昌明,李 选,宋世兵,等.肝门部胆道引流管折叠技术在肝移植后胆道非吻合口狭窄治疗中的应用[J].介入放射学杂志,2012,(02):136.
WANG Chang-ming,LI Xuan,SONG Shi-bing,et al.The application of biliary catheter folding technique in the treatment of hilar nonanastomotic biliary strictures after orthotopic liver transplantation[J].journal interventional radiology,2012,(12):136.
[5]赵玉峰,孙玉琴,韩晓静,等. 输卵管介入再通术后受孕时机的研究[J].介入放射学杂志,2012,(02):158.
ZHAO Yu-feng,SUN Yu-qin,HAN Xiao-jing,et al.The optimal time for conception after fallopian tube recanalization therapy[J].journal interventional radiology,2012,(12):158.
[6]含 笑,曹建民,史东宏,等.吉西他滨、顺铂动静脉联合化疗治疗晚期非小细胞肺癌的近期疗效分析[J].介入放射学杂志,2012,(02):119.
HAN Xiao,CAO Jian-min,SHI Dong-hong,et al.Bronchial artery infusion of Gemcitabine and Cisplatin combined with systemic chemotherapy for advanced non-small cell lung cancer: its short-term efficacy[J].journal interventional radiology,2012,(12):119.
[7]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良ＲＥＣＩＳＴ标准更可靠[J].介入放射学杂志,2012,(03):177.
. Ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ ｃｒｉｔｅｒｉｏｎ ｏｆ ｉｎｏｐｅｒａｂｌｅ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｍｏｄｉｆｉｅｄ ＲＥＣＩＳＴ ａｓ ａ ｍｏｒｅ ｒｅｌｉａｂｌｅ ｓｔａｎｄａｒｄ[J].journal interventional radiology,2012,(12):177.
[8]齐 立,李慎茂,俸军林,等. 动脉溶栓与机械碎栓联合动脉溶栓的对比分析[J].介入放射学杂志,2012,(03):180.
,,et al. Ｃｏｍｐａｒｉｓｏｎ ｏｆ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｅｆｆｉｃａｃｙ ｂｅｔｗｅｅｎ ｓｉｍｐｌｅ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ａｎｄ ｍｅｃｈａｎｉｃａｌ ｔｈｒｏｍｂｅｃｔｏｍｙ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ｆｏｒ ａｃｕｔｅ ｃｅｒｅｂｒａｌ ｉｎｆａｒｃｔｉｏｎ ａｔ ｉｔｓ ｕｌｔｒａｅａｒｌｙ ｓｔａｇｅ[J].journal interventional radiology,2012,(12):180.
[9]石 潆,赵 卫,沈 进,等.脑动静脉畸形栓塞治疗术并发颅内出血的原因及处理[J].介入放射学杂志,2012,(03):185.
,,et al.Ｉｎｔｒａｃｒａｎｉａｌ ｈｅｍｏｒｒｈａｇｅ ｄｕｅ ｔｏ ｅｍｂｏｌｉｚａｔｉｏｎ ｔｈｅｒａｐｙ ｆｏｒ ｃｅｒｅｂｒａｌ ａｒｔｅｒｉｏｖｅｎｏｕｓ ｍａｌｆｏｒｍａｔｉｏｎ： ｉｔｓ ｃａｕｓｅｓ ａｎｄ ｍａｎａｇｅｍｅｎｔ [J].journal interventional radiology,2012,(12):185.
[10]周 慷,李晓光,金征宇,等.清宫术前子宫动脉化疗栓塞术治疗瘢痕妊娠的疗效分析[J].介入放射学杂志,2012,(03):190.
,,et al.Ｔｈｅｒａｐｅｕｔｉｃ ａｎａｌｙｓｉｓ ｏｆ ｂｉｌａｔｅｒａｌ ｕｔｅｒｉｎｅ ａｒｔｅｒｙ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ ｐｅｒｆｏｒｍｅｄ ｂｅｆｏｒｅ ｕｔｅｒｉｎｅ ｄｉｌａｔｉｏｎ ａｎｄ ｃｕｒｅｔｔａｇｅ ｆｏｒ ｃｅｓａｒｅａｎ ｓｃａｒ ｐｒｅｇｎａｎｃｙ [J].journal interventional radiology,2012,(12):190.